{"entities":{"Q39945":{"pageid":30313,"ns":120,"title":"Item:Q39945","lastrevid":125203,"modified":"2026-08-13T05:33:43Z","type":"item","id":"Q39945","labels":{"mul":{"language":"mul","value":"5B5K.A"},"pt-br":{"language":"pt-br","value":"Defici\u00eancia de molibd\u00eanio"},"en":{"language":"en","value":"Molybdenum deficiency"}},"descriptions":{"pt-br":{"language":"pt-br","value":"O molibd\u00eanio funciona como cofator para um n\u00famero limitado de enzimas em humanos: sulfito oxidase, xantina oxidase e alde\u00eddo oxidase. Foi descrito um defeito metab\u00f3lico grave e raro que causa defici\u00eancia do cofator de molibd\u00eanio e impede que essas enzimas sejam sintetizadas. Poucos beb\u00eas com esses defeitos sobrevivem aos primeiros dias de vida e os que sobrevivem apresentam graves anormalidades neurol\u00f3gicas. Embora a defici\u00eancia de molibd\u00eanio relacionada a uma defici\u00eancia alimentar seja extremamente rara em humanos, ela foi descrita na nutri\u00e7\u00e3o parenteral total (NPT) de longo prazo como secund\u00e1ria \u00e0 administra\u00e7\u00e3o de sulfito. Os sintomas incluem: taquicardia, dor de cabe\u00e7a, cegueira noturna, irritabilidade e coma. As altera\u00e7\u00f5es bioqu\u00edmicas podem consistir em elevadas concentra\u00e7\u00f5es plasm\u00e1ticas de metionina , baixa concentra\u00e7\u00e3o s\u00e9rica de \u00e1cido \u00farico, altos n\u00edveis de tiossulfato urin\u00e1rio e baixos n\u00edveis urin\u00e1rios de \u00e1cido \u00farico e sulfato."},"en":{"language":"en","value":"Molybdenum functions as a cofactor for a limited number of enzymes in humans: sulphite oxidase, xanthine oxidase and aldehyde oxidase. A rare severe metabolic defect causing molybdenum cofactor deficiency and preventing these enzymes from being synthesized has been described. Few infants with such defects survive the first days of life, and those who survive have severe neurological abnormalities. Although molybdenum deficiency related to a dietary deficiency is extremely rare in humans, it has been described in long-term total parenteral nutrition as being secondary to the administration of sulphite. Symptoms include: tachycardia, headache, night blindness, irritability and coma. Biochemical changes can consist of elevated plasma and methionine concentration, low serum uric acid concentration, high urinary thiosulfate and low urinary uric acid and sulphate levels."}},"aliases":{},"claims":{"P68":[{"mainsnak":{"snaktype":"value","property":"P68","hash":"5b831027a0b207172c6ae8f04af8bd9222cd26cc","datavalue":{"value":"https://id.who.int/icd/entity/316007944","type":"string"},"datatype":"url"},"type":"statement","id":"Q39945$6502B464-9519-45FA-A68A-CDC4CB55048E","rank":"normal"}],"P67":[{"mainsnak":{"snaktype":"value","property":"P67","hash":"53f0f31341c5db00b61200b6c065f6487dceb8d3","datavalue":{"value":"CID11:5B5K.A","type":"string"},"datatype":"string"},"type":"statement","id":"Q39945$740F95BC-413D-4F33-A3F8-8DCE3AC21EEA","rank":"normal"}],"P70":[{"mainsnak":{"snaktype":"value","property":"P70","hash":"1a8e6494757e0cf0b7b93fb38ef2ff63c6b38766","datavalue":{"value":"dki-india-5B5K.A","type":"string"},"datatype":"string"},"type":"statement","id":"Q39945$DA3B9D58-BD0A-4C6B-B7A4-AACC8EEA44F7","rank":"normal"}],"P86":[{"mainsnak":{"snaktype":"value","property":"P86","hash":"a96031634b9f5dafddaf781bbba3adea6bb64ef4","datavalue":{"value":"Conclu\u00eddo","type":"string"},"datatype":"string"},"type":"statement","id":"Q39945$62C1907A-A55A-42EF-A336-E8B24549053D","rank":"normal"}],"P78":[{"mainsnak":{"snaktype":"value","property":"P78","hash":"5f9b5be68b7400da549761cf15abfdbc4d1e075b","datavalue":{"value":"https://pauloleads.com.br/cases-publicos/","type":"string"},"datatype":"url"},"type":"statement","id":"Q39945$AD913410-F497-41E2-BF6E-45B157A545A6","rank":"normal"}],"P80":[{"mainsnak":{"snaktype":"value","property":"P80","hash":"92b8222fcbb75718504f915073a3f43bd4003d18","datavalue":{"value":{"time":"+2026-08-13T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q39945$976E451A-B33D-4775-8E7E-29C3C9E93E03","rank":"normal"}],"P89":[{"mainsnak":{"snaktype":"value","property":"P89","hash":"deb1d9d74c0d337fd13f6c9dfe0671d6ebb6a404","datavalue":{"value":{"entity-type":"item","numeric-id":15483,"id":"Q15483"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q39945$70A170A0-795A-4C2D-B9F3-5C3827C8C6B3","rank":"normal"}]},"sitelinks":{}}}}